A Novel GUCY2C-CD3 T Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-3275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors

Science Translational Medicine
Medicine
2017English

A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2012English

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2016English

Development of PF-06671008, a Highly Potent Anti-P-Cadherin/Anti-Cd3 Bispecific DART Molecule With Extended Half-Life for the Treatment of Cancer

Antibodies
Drug DiscoveryAllergyImmunology
2016English

PS2 - 172 Preclinical Validation of a Novel CD33/CD3 Bispecific T-Cell Engager (BiTE) Antibody to Target Patient-Derived Glioblastoma Cells

Canadian Journal of Neurological Sciences
MedicineNeurology
2016English

SY13-1Vasohibin-2 Is a Novel Molecular Target for the Treatment of Gastrointestinal Cancers

Annals of Oncology
MedicineOncologyHematology
2018English

Cd20-TCB (Rg6026), a Novel “2:1” Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Efficient Elimination of Chronic Lymphocytic Leukaemia B Cells by Autologous T Cells With a Bispecific Anti-Cd19/Anti-Cd3 Single-Chain Antibody Construct

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

A Novel Bispecific Antibody Against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy